ArticleCancers2022

GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas.

Koichi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.